These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

623 related articles for article (PubMed ID: 15774441)

  • 1. Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit.
    Holtkamp M; Othman J; Buchheim K; Meierkord H
    J Neurol Neurosurg Psychiatry; 2005 Apr; 76(4):534-9. PubMed ID: 15774441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis and predictors of outcome of refractory generalized convulsive status epilepticus in adults treated in neurointensive care unit.
    Vooturi S; Jayalakshmi S; Sahu S; Mohandas S
    Clin Neurol Neurosurg; 2014 Nov; 126():7-10. PubMed ID: 25194304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A "malignant" variant of status epilepticus.
    Holtkamp M; Othman J; Buchheim K; Masuhr F; Schielke E; Meierkord H
    Arch Neurol; 2005 Sep; 62(9):1428-31. PubMed ID: 16157750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refractory status epilepticus: a prospective observational study.
    Novy J; Logroscino G; Rossetti AO
    Epilepsia; 2010 Feb; 51(2):251-6. PubMed ID: 19817823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrum and Predictors of Refractory Status Epilepticus in a Developing Country.
    Dubey D; Bhoi SK; Kalita J; Misra UK
    Can J Neurol Sci; 2017 Sep; 44(5):538-546. PubMed ID: 28446263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants and predictors of outcome in super refractory status epilepticus--a developing country perspective.
    Jayalakshmi S; Ruikar D; Vooturi S; Alladi S; Sahu S; Kaul S; Mohandas S
    Epilepsy Res; 2014 Nov; 108(9):1609-17. PubMed ID: 25246354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of refractory status epilepticus in adults: A retrospective population-based study.
    Kantanen AM; Reinikainen M; Parviainen I; Kälviäinen R
    Epilepsy Res; 2017 Jul; 133():13-21. PubMed ID: 28402834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perampanel in patients with refractory and super-refractory status epilepticus in a neurological intensive care unit.
    Rohracher A; Höfler J; Kalss G; Leitinger M; Kuchukhidze G; Deak I; Dobesberger J; Novak H; Pilz G; Zerbs A; Trinka E
    Epilepsy Behav; 2015 Aug; 49():354-8. PubMed ID: 25962657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refractory status epilepticus: a developing country perspective.
    Sinha S; Prashantha DK; Thennarasu K; Umamaheshwara Rao GS; Satishchandra P
    J Neurol Sci; 2010 Mar; 290(1-2):60-5. PubMed ID: 19954801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aborted and refractory status epilepticus in children: a comparative analysis.
    Lambrechtsen FA; Buchhalter JR
    Epilepsia; 2008 Apr; 49(4):615-25. PubMed ID: 18093148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Causes and outcomes of new onset status epilepticus and predictors of refractoriness to therapy.
    Jayalakshmi S; Vooturi S; Sahu S; Yada PK; Mohandas S
    J Clin Neurosci; 2016 Apr; 26():89-94. PubMed ID: 26822381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A one-year prospective study of refractory status epilepticus in Modena, Italy.
    Giovannini G; Monti G; Polisi MM; Mirandola L; Marudi A; Pinelli G; Valzania F; Girardis M; Nichelli PF; Meletti S
    Epilepsy Behav; 2015 Aug; 49():141-5. PubMed ID: 26074182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uric acid is a useful marker to differentiate between responsive and refractory status epilepticus.
    Choi JY; Hong JM; Kim TJ; Kim BG; Huh K
    Clin Neurol Neurosurg; 2019 Sep; 184():105454. PubMed ID: 31376771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refractory status epilepticus: frequency, risk factors, and impact on outcome.
    Mayer SA; Claassen J; Lokin J; Mendelsohn F; Dennis LJ; Fitzsimmons BF
    Arch Neurol; 2002 Feb; 59(2):205-10. PubMed ID: 11843690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perampanel Treatment for Refractory Status Epilepticus in a Neurological Intensive Care Unit.
    Ho CJ; Lin CH; Lu YT; Shih FY; Hsu CW; Tsai WC; Tsai MH
    Neurocrit Care; 2019 Aug; 31(1):24-29. PubMed ID: 30891695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting mortality of refractory status epilepticus.
    Tatlidil I; Ture HS; Akhan G
    Acta Neurol Scand; 2020 Feb; 141(2):123-131. PubMed ID: 31550052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of outcome in refractory status epilepticus.
    Hocker SE; Britton JW; Mandrekar JN; Wijdicks EF; Rabinstein AA
    JAMA Neurol; 2013 Jan; 70(1):72-7. PubMed ID: 23318514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refractory and super-refractory status epilepticus in adults: a 9-year cohort study.
    Delaj L; Novy J; Ryvlin P; Marchi NA; Rossetti AO
    Acta Neurol Scand; 2017 Jan; 135(1):92-99. PubMed ID: 27080243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of intravenous lacosamide for adjunctive treatment of refractory status epilepticus: a comparative cohort study.
    Sutter R; Marsch S; Rüegg S
    CNS Drugs; 2013 Apr; 27(4):321-9. PubMed ID: 23533010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (S)-Ketamine in Refractory and Super-Refractory Status Epilepticus: A Retrospective Study.
    Höfler J; Rohracher A; Kalss G; Zimmermann G; Dobesberger J; Pilz G; Leitinger M; Kuchukhidze G; Butz K; Taylor A; Novak H; Trinka E
    CNS Drugs; 2016 Sep; 30(9):869-76. PubMed ID: 27465262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.